Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)
Clinical trial NCT02759315 · TERMINATED
Trial details
- NCT number
- NCT02759315
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2017-07-27
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.